Find research datasets worth reusing

Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boost

ClinicalTrials.gov study NCT00489970. IPD Sharing: YES. Countries: 1. Publications: 2.

Efficacy and Safety of Polyoxidonium, Nasal and Sublingual Spray, 6 mg/ml in Children Aged 1-12 Years With ARI

ClinicalTrials.gov study NCT03840135. IPD Sharing: NO. Countries: 1. Publications: 0.

A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalize

ClinicalTrials.gov study NCT01969851. IPD Sharing: Not stated. Countries: 5. Publications: 1.

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH)

ClinicalTrials.gov study NCT05064397. IPD Sharing: Not stated. Countries: 9. Publications: 1.

Safety and Pharmacokinetic Study of Lumacaftor/Ivacaftor in Participants 1 to Less Than 2 Years of Age With Cystic Fibrosis, Homozygous for F508del

ClinicalTrials.gov study NCT03601637. IPD Sharing: NO. Countries: 2. Publications: 3.

1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)

ClinicalTrials.gov study NCT00929110. IPD Sharing: Not stated. Countries: 16. Publications: 2.

Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

ClinicalTrials.gov study NCT01634113. IPD Sharing: Not stated. Countries: 11. Publications: 2.

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

ClinicalTrials.gov study NCT04648241. IPD Sharing: YES. Countries: 1. Publications: 1.

A 1-year Multi-center, Prospective, Cohort Study in Patients With Chronic Obstructive Pulmonary Disease Treated With Long-acting Bronchodilator

ClinicalTrials.gov study NCT01794780. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Safety and Efficacy Study of Viaskin Peanut in Peanut-allergic Young Children 1-3 Years of Age

ClinicalTrials.gov study NCT03211247. IPD Sharing: NO. Countries: 8. Publications: 2.

Study of Rufinamide in Pediatric Subjects 1 to Less Than 4 Years of Age With Lennox-Gastaut Syndrome Inadequately Controlled With Other Anti-epileptic Drugs

ClinicalTrials.gov study NCT01405053. IPD Sharing: Not stated. Countries: 7. Publications: 4.

Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.

ClinicalTrials.gov study NCT01682876. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov study NCT01019694. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedule

ClinicalTrials.gov study NCT01562444. IPD Sharing: Not stated. Countries: 1. Publications: 1.

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

ClinicalTrials.gov study NCT00098059. IPD Sharing: Not stated. Countries: 2. Publications: 1.

Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-admi

ClinicalTrials.gov study NCT01939158. IPD Sharing: YES. Countries: 6. Publications: 1.

Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents

ClinicalTrials.gov study NCT02916862. IPD Sharing: YES. Countries: 1. Publications: 1.

Study of the Safety, Pharmacodynamics (PD) and Efficacy of KRN23 in Children From 1 to 4 Years Old With X-linked Hypophosphatemia (XLH)

ClinicalTrials.gov study NCT02750618. IPD Sharing: Not stated. Countries: 1. Publications: 2.

Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects ≥1 Month to <4 Years With Partial-onset Seizures

ClinicalTrials.gov study NCT02477839. IPD Sharing: Not stated. Countries: 26. Publications: 0.

T-cell And General Immune Response to Seasonal Influenza Vaccine (SLVP018) - Year 1, 2009

ClinicalTrials.gov study NCT01987349. IPD Sharing: NO. Countries: 1. Publications: 3.